Brief: aTyr Pharma Announces The Appointment Of Dalia R. Rayes As Head Of Commercial, Global Efzofitimod Franchise
26/03/2025 12:07
March 26 (Reuters) - aTyr Pharma Inc ATYR.O: ATYR PHARMA ANNOUNCES THE APPOINTMENT OF DALIA R. RAYES AS HEAD OF COMMERCIAL, GLOBAL EFZOFITIMOD FRANCHISE Source text: ID:nGNX59kD Further company coverage: ATYR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan